In summary, our data show that the GAS6-AXL and HGF-MET signaling axes play a critical role in cancer cell migration and invasion, demonstrating that simultaneous inhibition of these pathways contributes to the anti-cancer effects of cabozantinib. Here, MET is linked to cancer.